Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIR-Spheres with Cetuximab and Irinotecan in Colorectal Cancer Liver Metastases
NCT00766220Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Oct 2009
- Primary completion
- Jan 2012
- Modality
- Nanoparticles, Device-based Delivery
01
Overview
A Phase 2 trial of yttrium-90 in colorectal cancer (CRC), sponsored by University of Texas MD Anderson Cancer Center. Planned start Oct 2009; status: withdrawn.
02
Drugs
yttrium-90
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00766220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766220.